62.74 USD
↘ 1.45 (2.26%)LIVE (AS OF 03:22 PM EDT)
Arrowhead Research Corporation
ARWRNASDAQ • USD
Market: OPEN
Arrowhead Research Corporation (ARWR) is currently trading at $62.74. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Notable factors include negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 2, 2026.
Open?$64.76
High?$64.76
Low?$62.38
Prev. Close?$64.19
Volume?1.0M
Avg. Volume?2.0M
VWAP?$63.11
Rel. Volume?0.51x
Bid / Ask
Bid?$62.58 × 100
Ask?$66.01 × 100
Spread?$3.43
Midpoint?$64.30
Valuation & Ratios
Market Cap?9.1B
Shares Out?140.9M
Float?135.7M
Float %?96.3%
P/E Ratio?N/A
P/B Ratio?19.48
EPS?-$2.27
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
Themes
Employees
711
Market Cap
9.1B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1995-02-01
Address
177 E COLORADO BLVD
PASADENA, CA 91105
Phone: 626-696-4702
PASADENA, CA 91105
Phone: 626-696-4702
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?64
Momentum?48
Short Sent.?69
Piotroski F-Score?3/9Weak
Altman Z-Score?2.78Grey
Confidence?68%Moderate
Short InterestHigh
Short % of Float?6.83%Elevated
Short Interest?9.3M
Days to Cover?5.2
Free Float135.7M
Avg Daily Volume1.8M
Settlement Date2026-09-15
Financial Health
Current Ratio?5.90Strong
Quick Ratio?5.90Strong
Cash Ratio?0.19Low
Debt/Equity?1.86High
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?19.48HIGH▾
Peers100
S&P8
P/S?13.54HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-49.2CHEAP▾
S&P97
EV/Sales?14.75HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-68.7%WEAK▾
S&P3
ROA?-15.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-75111000
Enterprise Value?$9.9B
Fundamentals ratios updated end of day